Atypical Lobular Hyperplasia
📧 Sign up to get email alerts when something new happens for Atypical Lobular Hyperplasia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Ruxolitinib for Premalignant Breast Disease [Phase 2]
Phase 2 trial evaluating ruxolitinib for premalignant breast diseases (Ductal Carcinoma In Situ, Atypical Lobular Hyperplasia, Atypical Duct…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Randomized Double-Blind Phase II Trial of Baby Exemestane Versus Baby Tamoxifen in Post-Menopausal Women at High Risk for Breast Cancer [Phase 2]
Phase II randomized trial comparing baby exemestane to baby tamoxifen in post-menopausal women at high risk for breast cancer (not yet recru…
-
CLINICAL_TRIALS withdrawal · 2026-03-09Clinical Trial Update: Comparing Vacuum-Assisted Percutaneous Excision to Open Surgical Excision for Borderline or High-Risk Breast Lesions [NA]
A clinical trial comparing vacuum-assisted percutaneous excision to open surgical excision for borderline or high-risk breast lesions has be…
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: Adding a Genetic Risk Evaluation to Standard Breast Cancer Risk Assessment for African American and Hispanic Women
A Mayo Clinic-backed clinical trial is evaluating the addition of a genetic risk evaluation to standard breast cancer risk assessment specif…
-
CLINICAL_TRIALS trial_result · 2026-01-23Clinical Trial Update: Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk [Phase 2]
Phase 2 trial comparing oral tamoxifen, TamGel (topical tamoxifen), and control in women at increased risk for breast cancer or with atypica…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-12-05Clinical Trial Update: Breast Cancer Chemoprevention by SOM230, an IGF-I Action Inhibitor: A Proof of Principle Trial [Phase 1]
Phase 1 proof-of-principle trial evaluating SOM230 (pasireotide) as an IGF-I action inhibitor for breast cancer chemoprevention in high-risk…
-
CLINICAL_TRIALS trial_result · 2016-10-10Clinical Trial Update: Molecular Breast Imaging in Women With Atypia and LCIS [NA]
The Mayo Clinic-led clinical trial evaluating molecular breast imaging for women with atypical lobular hyperplasia, atypical ductal hyperpla…
-
CLINICAL_TRIALS trial_result · 2016-01-20Clinical Trial Update: Group-Based Lifestyle Intervention in Measuring Biomarker Levels in Participants at High Risk for Breast Cancer [NA]
The study reports that a group-based lifestyle intervention completed and collected biomarker data in participants at high risk for breast c…